Protocols, physiology, and trials of hydroxyethyl starch

New England Journal of Medicine

Volumn 367, Issue 13, 2012, Pages 1266-

  Chappell, Daniel ^a   Jacob, Matthias ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; LACTIC ACID;

CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; COLLOID; DISEASE ASSOCIATION; DISEASE SEVERITY; FLUID RESUSCITATION; HUMAN; LACTATE BLOOD LEVEL; LETTER; MORTALITY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; SEPSIS; THERAPY EFFECT; TREATMENT CONTRAINDICATION;

EID: 84866766183     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1209905     Document Type: Letter

References (2)

1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327. [Erratum, Crit Care Med 2008;36:1394-6.]
2. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.